Revenue
13.7 million USD
2024 Q2 · USD
Exact inputs and evidence
- Revenue: 13664000 USD Source
31 filing records in this dataset, filed from 2019-05-20 to 2024-08-12. Reported financial figures are available; chart coverage varies by period.
13.7 million USD
2024 Q2 · USD
-63.85%
2024 Q2 · %
-3.81 million USD
2024 Q2 · USD
-4.17 million USD
2024 Q2 · USD
28200000 USD
21000000 USD
49080486 shares
20.30% · 8.28 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
51.6 million USD
2023-07-01 – 2024-06-30
-23.8 million USD
2023-07-01 – 2024-06-30
-15.3 million USD
2023-07-01 – 2024-06-30
2.56 million USD
2023-07-01 – 2024-06-30
-17.9 million USD
2023-07-01 – 2024-06-30
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2024-08-12.
Financial data available through: 2023-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 30.93 million
–
Current period
USD 44.86 million
–
44855000 − 30933000 = 13922000 USD
30933000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source44855000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 24.45 million
–
Current period
−USD 19.17 million
–
-19171000 − -24449000 = 5278000 USD
-24449000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source-19171000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 16.77 million
–
Current period
−USD 15.44 million
–
-15441000 − -16773000 = 1332000 USD
-16773000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source-15441000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 1.41 million
–
Current period
USD 3.11 million
–
3105000 − 1408000 = 1697000 USD
1408000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source3105000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2019 2019-01-01 – 2019-12-31 | 14107681 | 30850390 Derived | -16742709 | 1755632 Derived | -18498341 | -15468450 Derived | Source
|
| 2020 2020-01-01 – 2020-12-31 | 16483000 | 30176000 Derived | -13693000 | 1911000 Derived | -15604000 | -15046000 Derived | Source
|
| 2021 2021-01-01 – 2021-12-31 | 22165000 | 39716000 Derived | -17551000 | -87000 Derived | -17464000 | -19203000 Derived | Source
|
| 2022 2022-01-01 – 2022-12-31 | 30933000 | 53304000 Derived | -22371000 | 2078000 Derived | -24449000 | -18181000 Derived | Source
|
| 2023 2023-01-01 – 2023-12-31 | 44855000 | 63634000 Derived | -18779000 | 392000 Derived | -19171000 | -18546000 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2019 | Revenue | 14107681 |
|
| 2020 | Revenue | 16483000 |
|
| 2021 | Revenue | 22165000 |
|
| 2022 | Revenue | 30933000 |
|
| 2023 | Revenue | 44855000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2019 | Year over year | No prior comparable period |
|
| 2020 | Year over year | 16.8% |
|
| 2021 | Year over year | 34.5% |
|
| 2022 | Year over year | 39.6% |
|
| 2023 | Year over year | 45% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2019 | Operating margin | -118.7% |
|
| 2020 | Operating margin | -83.1% |
|
| 2021 | Operating margin | -79.2% |
|
| 2022 | Operating margin | -72.3% |
|
| 2023 | Operating margin | -41.9% |
|
| 2019 | Net margin | -131.1% |
|
| 2020 | Net margin | -94.7% |
|
| 2021 | Net margin | -78.8% |
|
| 2022 | Net margin | -79% |
|
| 2023 | Net margin | -42.7% |
|
| 2019 | Free cash flow margin | -109.6% |
|
| 2020 | Free cash flow margin | -91.3% |
|
| 2021 | Free cash flow margin | -86.6% |
|
| 2022 | Free cash flow margin | -58.8% |
|
| 2023 | Free cash flow margin | -41.3% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2019 | Operating cash flow | -14645437 |
|
| 2020 | Operating cash flow | -14399000 |
|
| 2021 | Operating cash flow | -18592000 |
|
| 2022 | Operating cash flow | -16773000 |
|
| 2023 | Operating cash flow | -15441000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2019 | Free cash flow | -15468450 |
|
| 2020 | Free cash flow | -15046000 |
|
| 2021 | Free cash flow | -19203000 |
|
| 2022 | Free cash flow | -18181000 |
|
| 2023 | Free cash flow | -18546000 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2019 | Liabilities / assets | 171.5% |
|
| 2020 | Liabilities / assets | 88.8% |
|
| 2021 | Liabilities / assets | 53.8% |
|
| 2022 | Liabilities / assets | 95.6% |
|
| 2023 | Liabilities / assets | 65% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2019 | Current assets / current liabilities | 1.12× |
|
| 2020 | Current assets / current liabilities | 1.63× |
|
| 2021 | Current assets / current liabilities | 3.63× |
|
| 2022 | Current assets / current liabilities | 1.53× |
|
| 2023 | Current assets / current liabilities | 2.41× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2019 2019-01-01 – 2019-12-31 | −USD 18.5 million Exact valueExact value: -18498341 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 14.65 million Exact valueExact value: -14645437 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 823,013 Exact valueExact value: 823013 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 15.47 million Calculation and evidence-14645437 − 823013 USD Exact free cash flow: -15468450 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2020 2020-01-01 – 2020-12-31 | −USD 15.6 million Exact valueExact value: -15604000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 14.4 million Exact valueExact value: -14399000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 647,000 Exact valueExact value: 647000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 15.05 million Calculation and evidence-14399000 − 647000 USD Exact free cash flow: -15046000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2021-01-01 – 2021-12-31 | −USD 17.46 million Exact valueExact value: -17464000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 18.59 million Exact valueExact value: -18592000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 611,000 Exact valueExact value: 611000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 19.2 million Calculation and evidence-18592000 − 611000 USD Exact free cash flow: -19203000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 24.45 million Exact valueExact value: -24449000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 16.77 million Exact valueExact value: -16773000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.41 million Exact valueExact value: 1408000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 18.18 million Calculation and evidence-16773000 − 1408000 USD Exact free cash flow: -18181000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 19.17 million Exact valueExact value: -19171000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 15.44 million Exact valueExact value: -15441000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 3.11 million Exact valueExact value: 3105000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 18.55 million Calculation and evidence-15441000 − 3105000 USD Exact free cash flow: -18546000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
31 filings · 1,445 latest values · 1,445 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001769804, 1769804, AUGX, edgar:1769804
Also known as AUGMEDIX, INC., Augmedix, Inc., Malo Holdings Corp